Massachusetts Marijuana Regulators Say They Have Received No Federal Guidance on DEA Registration Requirements

The Massachusetts Cannabis Control Commission says it has received no implementation guidance from federal agencies concerning the ongoing rollout of Schedule III medical marijuana registrations, even as the Drug Enforcement Administration (DEA) continues processing applications from state-licensed businesses.

In a bulletin issued November 18, the commission informed licensed marijuana establishments and medical marijuana treatment centers that it is monitoring federal developments but cannot currently provide guidance on how DEA registration requirements apply to individual businesses.

“The Commission has not received implementation guidance from any federal agencies regarding these developments and cannot provide guidance regarding DEA registration requirements or the interpretation or application of federal laws, regulations, or policies,” the agency stated.

The bulletin follows the federal government’s April 28 rescheduling order, which moved marijuana covered by qualifying state medical marijuana licenses, along with Food and Drug Administration-approved marijuana products, from Schedule I to Schedule III of the Controlled Substances Act.

The order also established a federal registration process for qualifying medical marijuana businesses, with the DEA subsequently beginning to issue registrations and publish information concerning companies that submitted applications within the initial registration window.

Massachusetts regulators specifically referenced the DEA’s recently published list of timely medical marijuana applicants, sharing the federal document with state licensees for informational purposes.

However, the commission emphasized that responsibility for administering and enforcing federal marijuana laws remains outside its jurisdiction.

The agency also said it cannot offer legal, tax or business advice about how federal rescheduling developments may affect individual licensees, registered businesses or other participants in Massachusetts’ regulated marijuana market.

Despite the federal changes, Massachusetts’ existing marijuana regulations remain in effect.

“Currently, these federal developments do not change the Commission’s administration of Massachusetts cannabis laws and regulations,” the bulletin states.

The commission said businesses remain responsible for complying with all applicable state requirements, including the regulations governing recreational marijuana establishments and medical marijuana treatment centers.

The statement highlights the continuing distinction between federal and state marijuana oversight as the DEA implements the new medical marijuana registration framework.

Although qualifying medical marijuana products have been moved to Schedule III and federal registrations are being issued, Massachusetts regulators say they have not received the federal instructions needed to provide businesses with additional guidance on the process.

The commission said it will continue monitoring federal developments while administering and enforcing the state’s existing marijuana laws.